Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

McVeigh Brian — Larimar Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / McVeigh Brian

McVeigh Brian

Chief Business Officer at Larimar Therapeutics, Inc. · on record since May 30, 2018

Insider trading activity of McVeigh Brian

Transactions on record: 2; since May 30, 2018

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jan 24, 2019

Figures computed from official regulatory filings — methodology.

Companies where McVeigh Brian has traded

Larimar Therapeutics, Inc.2 tx · Jan 24, 2019

Track record of McVeigh Brian

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of McVeigh Brian

Co-insiders of McVeigh Brian

Allen Patricia LLarimar Therapeutics, Inc.
Atlas Venture Associates VII, Inc.Larimar Therapeutics, Inc.
Atlas Venture Associates VII, L.P.Larimar Therapeutics, Inc.
Atlas Venture Fund VII L PLarimar Therapeutics, Inc.
Barrett PeterLarimar Therapeutics, Inc.
BEN-MAIMON CAROLELarimar Therapeutics, Inc.
Booth BruceLarimar Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Celano MichaelLarimar Therapeutics, Inc.

CHONDRIAL THERAPEUTICS HOLDINGS, LLCLarimar Therapeutics, Inc.

Clayton RussellLarimar Therapeutics, Inc.

Daniel Thomas OLarimar Therapeutics, Inc.

DEERFIELD CAPITAL LPLarimar Therapeutics, Inc.

Deerfield Healthcare Innovations Fund, L.P.Larimar Therapeutics, Inc.

DEERFIELD MANAGEMENT CO /NYLarimar Therapeutics, Inc.

Deerfield Mgmt HIF, L.P.Larimar Therapeutics, Inc.

Deerfield Mgmt III, L.P.Larimar Therapeutics, Inc.

Deerfield Mgmt IV, L.P.Larimar Therapeutics, Inc.

DEERFIELD PARTNERS, LPLarimar Therapeutics, Inc.

Deerfield Private Design Fund III, L.P.Larimar Therapeutics, Inc.

Deerfield Private Design Fund IV, L.P.Larimar Therapeutics, Inc.

EVERETT WENDYLarimar Therapeutics, Inc.

Flynn James ELarimar Therapeutics, Inc.

Goldberg Avi Y.Larimar Therapeutics, Inc.

Hamilton Thomas EdwardLarimar Therapeutics, Inc.

Hatfield Jeffrey S.Larimar Therapeutics, Inc.

Heller Frances KLarimar Therapeutics, Inc.

Hughes Thomas E.Larimar Therapeutics, Inc.

KIM DENNIS DLarimar Therapeutics, Inc.

LAMATTINA JOHN LLarimar Therapeutics, Inc.

LEFF JONATHAN SLarimar Therapeutics, Inc.

LEVIN MARK JLarimar Therapeutics, Inc.

Loustau PatrickLarimar Therapeutics, Inc.

McDonough Cameron GeoffreyLarimar Therapeutics, Inc.

PEREZ ROBERT JLarimar Therapeutics, Inc.

Secor AliciaLarimar Therapeutics, Inc.

Shankar GopiLarimar Therapeutics, Inc.

SHERMAN JEFFREY WLarimar Therapeutics, Inc.

Singhal PriyaLarimar Therapeutics, Inc.

STARR KEVIN PLarimar Therapeutics, Inc.

TEPPER ROBERT ILarimar Therapeutics, Inc.

Third Rock Ventures GP, L.P.Larimar Therapeutics, Inc.

THIRD ROCK VENTURES LPLarimar Therapeutics, Inc.

THOMAS FRANK ELarimar Therapeutics, Inc.

Truitt JosephLarimar Therapeutics, Inc.

TRV GP, LLCLarimar Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Larimar Therapeutics, Inc.	Jan 24, 2019	AwardD	125,000	0.00 USD	$0	SEC
Larimar Therapeutics, Inc.	May 30, 2018	AwardD	225,000	0.00 USD	$0	SEC